🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →
S&P 500: 763.96 -1.2% NASDAQ 100: 704.47 -2.9% Dow Jones: 534.08 -0.5%

Bearing Point Capital - Q4 2025 13F Filings

BE

Bearing Point Capital, LLC

CIK: 0002052916
Address: Minnesota Bloomington 3800 American Blvd. West Suite 935
$639.67 M
Portfolio Value
183
Assets Held
Reporting Period: Q4 2025
Filing Status:
Active
Last Updated: 08/11/2026

Portfolio Summary (Q4 2025)

View Full Portfolio Analysis

Top Buys

Q4 2025
1. AR Antero Resources Corporation
+$4.28 M
2. VHT Vanguard Health Care Etf
+$3.53 M
3. ALAB Astera Labs
+$3.52 M
4. BOTZ Global X Robotics & Artificial Intelligence Etf
+$3.5 M
5. EWG Ishares Msci Germany Etf
+$3.19 M

Top Sells

Q4 2025
1. SHY Ishares 1-3 Year Treasury Bond Etf
−$4.54 M
2. UNH Unitedhealth Group Incorporated
−$4.07 M
3. VEEV Veeva Systems
−$2.98 M
4. VCR Vanguard Consumer Discretionary Etf
−$2.4 M
5. VGSH Vanguard Short-Term Treasury Etf
−$1.96 M

Asset Allocation

Stocks/ETFs
+10.17%
$627.66 M 98.12%
Options
$0 0.00%
Debt
+5.16%
$603,576 0.09%
Other
+6.74%
$11.4 M 1.78%

Sector Allocation (Stocks)

Bearing Point Capital Q4 2025 Filing Summary

Bearing Point Capital, LLC filed its 13F report for Q4 2025 on February 10, 2026. The portfolio totaled 639.67 M reflecting a +10.10% change from the prior quarter, spanning 183 assets. The top 10 holdings comprised 29.2% of the portfolio, with Financials as the largest sector allocation. Quarterly activity included 29 new positions and 11 complete exits.

Report Type

Status

Data Summary

Items:

Total Value:

Actions

Issuer Name Class Value Shares Option Type

FAQs for Bearing Point Capital’s Q4 2025 Filing

Bearing Point Capital submitted their Form 13F-HR for the Q4 2025 period on 02/10/2026. This was the only submission for the quarter.

In the Q4 2025 filing, Bearing Point Capital reported a managed portfolio value of 639.67 M, consisting of 183 individual positions.

This page displays the raw filing documents. To see which stocks Bearing Point Capital bought or sold during Q4 2025, please visit Bearing Point Capital's Portfolio Analysis page.